BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10230505)

  • 1. Cytotoxicity of two novel cisplatin analogues, (CPA)2Pt[DOLYM] and (DACH)Pt[DOLYM], to human cancer cells in vitro.
    Choi SU; Kim KH; Choi EJ; Park SH; Kim KM; Shon YS; Lee CO
    Arch Pharm Res; 1999 Apr; 22(2):151-6. PubMed ID: 10230505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
    Pang SK; So WK; Ho YP; Au-Yeung CF
    Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antitumor activity [correction for activitiy] of trans(+/-)-1,2-diaminocyclo- hexaneglutamatoplatinum(II) formulated with stealth liposome.
    Han I; Kim OJ; Lee GY; Sung YK; Song R; Sohn YS
    Bioorg Med Chem; 2003 Dec; 11(24):5443-7. PubMed ID: 14642589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholic acid-carboplatin compounds (CarboChAPt) as models for specific drug delivery: synthesis of novel carboplatin analogous derivatives and comparison of the cytotoxic properties with corresponding cisplatin compounds.
    Paschke R; Kalbitz J; Paetz C; Luckner M; Mueller T; Schmoll HJ; Mueller H; Sorkau E; Sinn E
    J Inorg Biochem; 2003 Apr; 94(4):335-42. PubMed ID: 12667704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study on the anti-tumor effect of CDDP derivatives against the gastric cancer cell lines].
    Nitta A; Chung YS; Kato Y; Yashiro M; Maeda K; Kubo T; Nakata B; Okuno M; Sowa M
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):701-3. PubMed ID: 8154897
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
    Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers.
    Monk BJ; Alberts DS; Burger RA; Fanta PT; Hallum AV; Hatch KD; Salmon SE
    Gynecol Oncol; 1998 Nov; 71(2):308-12. PubMed ID: 9826477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bimodal effects of 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on cell cycle checkpoints.
    Kuang J; He G; Huang Z; Khokhar AR; Siddik ZH
    Clin Cancer Res; 2001 Nov; 7(11):3629-39. PubMed ID: 11705886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and cytotoxic activity of dextran carrying cis-dichloro(cyclohexane-trans-l-1,2-diamine)platinum(II) complex.
    Ohya Y; Masunaga T; Baba T; Ouchi T
    J Biomater Sci Polym Ed; 1996; 7(12):1085-96. PubMed ID: 8880440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel.
    Rixe O; Ortuzar W; Alvarez M; Parker R; Reed E; Paull K; Fojo T
    Biochem Pharmacol; 1996 Dec; 52(12):1855-65. PubMed ID: 8951344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin is active in vitro against human melanoma cell lines: comparison with cisplatin and carboplatin.
    Mohammed MQ; Retsas S
    Anticancer Drugs; 2000 Nov; 11(10):859-63. PubMed ID: 11142694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.
    Alberts DS; Fanta PT; Running KL; Adair LP; Garcia DJ; Liu-Stevens R; Salmon SE
    Cancer Chemother Pharmacol; 1997; 39(6):493-7. PubMed ID: 9118460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin.
    Twentyman PR; Wright KA; Mistry P; Kelland LR; Murrer BA
    Cancer Res; 1992 Oct; 52(20):5674-80. PubMed ID: 1327513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane.
    Yu CW; Li KK; Pang SK; Au-Yeung SC; Ho YP
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1686-91. PubMed ID: 16386904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
    Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of platinum analogs against human lung cancer cell lines and tumor specimens.
    Yonei T; Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Moritaka T; Shibayama T; Tabata M; Segawa Y; Takigawa N
    Acta Med Okayama; 1993 Aug; 47(4):233-41. PubMed ID: 8213217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA sequence selectivity of cisplatin analogues in intact human cells.
    Murray V; Whittaker J; McFadyen WD
    Chem Biol Interact; 1998 Mar; 110(1-2):27-37. PubMed ID: 9566723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.